Evidence & regulatory context
- Mechanism
- Tissue-derived graft; no ChEMBL entity. ClinicalTrials.gov search for amniotic membrane nerve conduit grafts returned no matching human trial.
- Target
- Not recorded
- Injury models
- Other
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatOtherSprague-DawleySurgical implantation as a segmental interpositional arterial graftHand-constructed tubed conduits of varying diameters and le…At the time of defect creation
Model: Surgically created femoral and aortic arterial defects requiring interpositional grafting
Patency rates varied from 60 to 90 per cent, with all grafts showing marked reendothelialisation within 3 to 4 weeks postoperatively.
Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.
